Author Archives: cmccormick

HEORStrategies’ Dr. Naomi Sacks presented on prevalence and treatment failure in UTI and acute cystitis at IDWeek 2023

HEORStrategies’ scientist Dr. Naomi Sacks, along with clinicians and industry leaders, presented study results of uncomplicated UTI (uUTI) in the US and acute cystitis in Japan. In their US-based study, Sacks and colleagues analyzed US healthcare claims data and found that uUTI treatment failure is associated with significantly higher healthcare resource utilization and costs among adult women in the US, highlighting the importance of appropriate empiric antibiotic selection. In their Japan-based study, Sacks and colleagues used Japanese healthcare claims data and found that the burden of acute uncomplicated cystitis is moderate, affecting 6-8.6% of adult Japanese women each year. These studies were presented at IDWeek, October 11-15, 2023.  Please contact Dr. Naomi Sacks at nsacks@heorstrategies.com for additional information.

  1. Cost Burden of Patients with Oral Antibiotic Treatment Failure for Uncomplicated Urinary Tract Infection in the United States (Poster 214844)
  2. Prevalence of Acute Uncomplicated Cystitis in Japan (Poster 218752)